nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

01.02.2014 | Short Communication

Evaluation of autonomic nervous system by salivary alpha-amylase level and heart rate variability in patients with schizophrenia

verfasst von: Masa Ieda, Tsuyoshi Miyaoka, Rei Wake, Kristian Liaury, Keiko Tsuchie, Michiyo Fukushima, Tomoko Araki, Satoko Ezoe, Takuji Inagaki, Jun Horiguchi

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Several researches indicate that autonomic nervous system (ANS) dysfunction in patients with schizophrenia. Recently, salivary alpha-amylase (sAA) has been employed as a useful marker for ANS function. We investigated the extent of ANS dysfunction by measuring sAA and heart rate variability (HRV) of 25 patients with schizophrenia compared with controls. Schizophrenia group demonstrated a significant increase in sAA and markedly lower parasympathetic nervous system (PNS) activity in the HRV. However, there were no significant differences between two groups in sympathetic nervous system (SNS) activity. We concluded that PNS might be suppressed and the SNS shows relatively high activity in schizophrenia.

Rechlin T, Claus D, Weis M (1994) Heart rate variability in schizophrenic patients and changes of autonomic heart rate parameters during treatment with clozapine. Biol Psychiatry 35:888–892PubMedCrossRef

Okada T, Toichi M, Sakihama M (2003) Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function inschizophrenia. J Clin Psychopharmacol 23:441–447PubMedCrossRef

Bär KJ, Letzsch A, Jochum T, Wagner G, Greiner W, Sauer H (2005) Loss of efferent vagal activity in acute schizophrenia. J Psychiatr Res 39:519–527PubMedCrossRef

Conny M, Louis A, Jeroen C, Gerard B, Herman P (1993) Heart rate variability. Ann Intern Med 118:436–447CrossRef

Moritani T, Hayashi T, Shinohara M, Mimasa F, Masuda I, Nakao K (1995) Sympatho-vagal activities of NIDDM patients during exercise as determined by heart rate spectral analysis. In: Kawamori R, Vranic M, Horton ES, Kubota M (eds) Glucose Fluxes, Exercise and Diabetes. Smith Gordon, London., pp 91–96

Davy KP, DeSouza CA, Jones PP, Seals DR (1998) Elevated heart rate variability in physically active young and older adult women. Clin Sci 94:579–584PubMed

Mujica-Parodi LR, Yeragani V, Malaspina D (2005) Nonlinear complexity and spectral analyses of heart rate variability in medicated and unmedicated patients with schizophrenia. Neuropsychobiology 51:10–15PubMedCentralPubMedCrossRef

Matsumoto T, Ushiroyama T, Kimura T, Sakuma K, Moritani T (2007) Therapeutic effects of psychological treatment in the outpatient climacteric clinic evaluated with an index of autonomic nervous system activity. J Jpn Menopause Soc 15:135–145CrossRef

Ue H, Masuda I, Yoshitake Y, Inazumi T, Moritani T (2000) Assessment of cardiac autonomic nervous activities by means of ECG R–R interval power spectral analysis and cardiac depolarization process. Ann Noninvasive Electrocardiol 5:336–345CrossRef

10.

Ruschena D, Mullen PE, Burgess P, Cordner SM, Barry-Walsh J, Drummer OH et al (1998) Sudden death in psychiatric patients. Br J Psychiatry 172:331–336PubMedCrossRef

11.

Druss BG, Bradfold DW, Rosenheck RA, Radford MJ, Krumholz HM (2000) Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 283:506–511PubMedCrossRef

12.

Hennekens CH, Hennekens AR, Hollar D, Casey DE (2005) Schizophrenia and increased risks of cardiovascular disease. Am Heart J 150:1115–1121PubMedCrossRef

13.

Kyunghee L, Jeongeon P, Jeongim C, Chang Gi P (2011) Heart rate variability and metabolic syndrome in hospitalized patients with schizophrenia. J Korean Acad Nurs 41:788–794CrossRef

14.

Toichi M, Kubota Y, Murai T, Kamio Y, Sakihama M, Toriuchi T et al (1999) The influence of psychotic states on the autonomic nervous system in schizophrenia. Int J Psychophysiol l 31:147–154CrossRef

15.

Fujibayashi M, Matsumoto T, Kishida I, Kimura T, Ishii C, Ishii N et al (2009) Autonomic nervous system activity and psychiatric severity in schizophrenia. Psychiatry Clin Neurosci 63:538–545PubMedCrossRef

16.

Hempel RJ, Tulen JHM, van Beveren NJM et al (2009) Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia. J Psychopharmacol 23:697–707PubMedCrossRef

17.

Nater UM, Rohleder N, Gaab J, Berger S, Jud A, Kirschbaum C et al (2005) Human salivary alpha-amylase reactivity in a psychosocial stress paradigm. Int J Psychophysiol 55:333–342PubMedCrossRef

18.

Nater UM, Rohleder N (2009) Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology 34:486–496PubMedCrossRef

19.

Rohleder N, Nater UM, Wolf JM, Ehlert U, Kirschbaum C (2004) Psychosocial stress-induced activation of salivary alpha-amylase. An indicator of sympathetic activity? Ann N Y Acad Sci 1032:258–263PubMedCrossRef

20.

Gordis EB, Granger DA, Susman EJ, Trickett PK (2006) Asymmetry between salivary cortisol and alpha-amylase reactivity to stress: relation to aggressive behavior in adolescents. Psychoneuroendocrinology 31:976–987PubMedCrossRef

21.

Yamaguchi M, Deguchi M, Wakasugi J, Ono S, Takai N, Higashi T et al (2006) Hand-held monitor of sympathetic nervous system using salivary amylase activity and its validation by driver fatigue assessment. Biosens Bioelectron 21:1007–1014PubMedCrossRef

22.

Thoma MV, Kirschbaum C, Wolf JM, Rohleder N (2012) Acute stress responses in salivary alpha-amylase predict increases of plasma norepinephrine. Biol Psychol 91:342–348PubMedCrossRef

23.

Inagaki T, Miyaoka T, Okazaki S, Yasuda H, Kawamukai T, Utani E et al (2010) High salivary alpha-amylase levels in patients with schizophrenia: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 34:688–691PubMedCrossRef

24.

Yamaguchi M, Kanemori T, Kanemaru M, Takai N, Mizuno Y, Yoshida H (2004) Performance evaluation of salivary amylase activity monitor. Biosens Bioelectron 20:491–497PubMedCrossRef

25.

Yamaguchi M, Wakasugi J, Sakakima J (2008) Competitive and product inhibition-based a-amylase activity analysis method. Clin Biochem 41:325–330PubMedCrossRef

26.

Higashi T, Mizuno Y, Oonishi M, Takeda K, Yamaguchi M. Nonverbal communication tool for children with severe motor and intellectual disabilities using biochemical measurement. In: Medicine and Biology 27th Annual Conference; Sep 1, 2005, Shanghai, China. Abstract NR4:3538

27.

Inagaki T, Ieda M, Yamashia S, Miyaoka T, Horiguchi J (2011) Salivary alpha-amylase reactivity under psycho-physiological stress. A nonverbal communication measurement tool? J Behav Brain Sci 1:12–15CrossRef

28.

Nater UM, Rohleder N, Schlotz W, Ehlert U, Kirschbaum C (2007) Determinants of the diurnal course of salivary alpha-amylase. Psychoneuroendocrinology 32:392–401PubMedCrossRef

29.

Noto Y, Sato T, Kudo M, Kurata K, Hirota K (2005) The relationship between salivary biomarkers and state-trait anxiety inventory score under mental arithmetic stress: a pilot study. Anesth Analg 101:1873–1876PubMedCrossRef

30.

Nater UM, Marca RL, Florin L, Moses A, Langhans W, Koller MM et al (2006) Stress-induced changes in human salivary alpha-amylase activity-associations with adrenergic activity. Psychoneuroendocrinology 31:49–58PubMedCrossRef

31.

Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ (1981) Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213:220–222PubMedCrossRef

32.

Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P et al (1986) Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 59:178–193PubMedCrossRef

33.

Matsumoto T, Miyawaki T, Ue H, Kanda T, Zenji C, Moritani T (1999) Autonomic responsiveness to acute cold exposure in obese and non-obese young women. Int J Obes Relat Metab Disord 23:793–800PubMedCrossRef

34.

Moritani T, Kimura T, Hamada T, Nagai N (2005) Electrophysiology and kinesiology for health and disease. J Electromyogr Kinesiol 15:240–255PubMedCrossRef

35.

Takai N, Yamaguchi M, Aragaki T, Eto K, Uchihashi K, Nishikawa Y (2004) Effect of psychological stress on the salivary cortisol and amylase levels in healthy young adults. Arch Oral Biol 49:963–968PubMedCrossRef

36.

van Stegeren A, Rohleder N, Everaerd W, Wolf OT (2006) Salivary alpha amylase as marker for adrenergic activity during stress: effect of beta blockade. Psychoneuroendocrinology 31:137–141PubMedCrossRef

37.

Skosnik PD, Chatterton RT Jr, Swisher T, Park S (2000) Modulation of attentional inhibition by norepinephrine and cortisol after psychological stress. Int J Psychophysiol 36:59–68PubMedCrossRef

38.

Shirasaki S, Fujii H, Takahashi M, Takahashi M, Sato T, Ebina M et al (2007) Correlation between salivary alpha-amylase activity and pain scale in patients with chronic pain. Reg Anesth Pain Med 32:120–123PubMed

39.

Bär KJ, Boettger MK, Schulz S, Harzendorf C, Agelink MW, Yeragani VK et al (2008) The interaction between pupil function and cardiovascular regulation in patients with acute schizophrenia. Clin Neurophysiol 119:2209–2213PubMedCrossRef

40.

Bär KJ, Wernich K, Boettger S, Cordes J, Boettger MK, Löffler S et al (2008) Relationship between cardiovagal modulation and psychotic state in patients with paranoid schizophrenia. Psychiatry Res 157:255–257PubMedCrossRef

Titel: Evaluation of autonomic nervous system by salivary alpha-amylase level and heart rate variability in patients with schizophrenia
verfasst von: Masa Ieda
Tsuyoshi Miyaoka
Rei Wake
Kristian Liaury
Keiko Tsuchie
Michiyo Fukushima
Tomoko Araki
Satoko Ezoe
Takuji Inagaki
Jun Horiguchi
Publikationsdatum: 01.02.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 1/2014
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-013-0411-6

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2014

Investigation of the hostile attribution bias toward ambiguous facial cues in antisocial violent offenders

Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions

The schizoaffective disorder diagnosis: a conundrum in the clinical setting

Altered emotion processing circuits during the anticipation of emotional stimuli in women with borderline personality disorder